An Open Label, Non Randomized , One Sequence, Add-On Study to Investigate the Effects of PTK787/ZK 222584 on the Pharmacokinetics and Pharmacodynamics of Warfarin at Steady-States in Cancer Patients.
Phase of Trial: Phase I
Latest Information Update: 08 Oct 2015
At a glance
- Drugs Vatalanib (Primary) ; Warfarin (Primary)
- Indications Solid tumours
- Focus Pharmacodynamics
- 03 Aug 2012 Actual end date (Aug 2012) added as reported by ClinicalTrials.gov.
- 01 Aug 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Jun 2010 Planned end date (Jul 2008) added as reported by ClinicalTrials.gov.